Suboxone: A Primer
The Carlat Psychiatry Report, Volume 4, Number 6, June 2006
https://www.thecarlatreport.com/newsletter-issue/tcprv4n6/
Issue Links: Learning Objectives | Editorial Information
Topics: Substance Abuse
Suboxone (buprenorphine/naloxone) was approved by the FDA on October 8, 2002 for the treatment of opioid addiction. Until the approval of Suboxone, we had two options for treating opioid addiction— naltrexone and methadone.
You can't view details of this content, please login or buy subscription here
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.